THREAD Enhances Digital Health Technology Integrations for Real-Time Data in Clinical Trials
New data ingestion capabilities enable Biopharma sponsors and CROs to integrate fit-for-purpose Digital Health Technologies (DHTs) in global studies faster, reducing standard integration timelines from months to days
CARY, N.C., 20 OCT 2026 – THREAD, a leading no-code clinical research technology platform with scientific consulting for decentralized clinical trials (DCT) and electronic clinical outcome assessments (eCOA), today announced expanded capabilities designed to simplify and accelerate the integration of connected devices, wearables, and other DHTs into clinical trials. Built on THREAD’s configurable data ingestion architecture, the capabilities enable sponsors and CROs to integrate fit-for-purpose DHTs without the lengthy custom development traditionally associated with device-enabled clinical research. By standardizing how device data is ingested, mapped, and incorporated into study workflows, THREAD can help reduce integration timelines from months to days while supporting continuous, high-frequency data collection across global trials.
As clinical trials increasingly incorporate wearables, sensors, connected medical devices, and other DHTs, study teams are managing growing volumes of objective data from multiple sources. Traditional integrations can require significant custom engineering and validation, creating additional cost, complexity, and potential delays to study startup.
THREAD’s configurable approach removes much of this integration burden by providing a common infrastructure for connecting device data with participant activities, study workflows, alerts, and operational reporting.
Key capabilities include:
- No-Code Study Configuration: THREAD’s Configurator enables study teams to map device data, participant workflows, schedules, forms, alerts, and other study requirements without relying on custom software development.
- Fit-for-Purpose Device Flexibility: Sponsors can select appropriate commercial, medical, wearable, or connected technologies based on protocol requirements rather than being limited to a predefined device ecosystem.
- Continuous Data Ingestion: THREAD can ingest and standardize high-frequency DHT data alongside eCOA, participant, clinical, and operational data to provide study teams with a more connected view of trial activity.
- Flexible Participant Experience: THREAD’s Participant App supports iOS, Android, and Web experiences across provisioned-device and Bring Your Own Device (BYOD) models, helping participants complete study activities while supporting automated data synchronization.
- Real-Time Study Oversight: Device and participant data can be incorporated into configurable dashboards, alerts, and workflows within THREAD’s Study Portal, helping research teams identify relevant signals and take appropriate action.
THREAD’s configurable approach has been proven in large-scale clinical research using the Empatica EmbracePlus wearable, where THREAD supported continuous data collection of physiological and activity data, including temperature, pulse, sleep, and steps, across a multi-thousand-participant study. By connecting incoming wearable data to configurable workflows and alerts, THREAD helped research teams identify relevant signals and support timely follow-up, demonstrating how DHT data can become an actionable part of the broader clinical trial environment.
“Digital Health Technologies can provide incredibly valuable objective evidence, but integrating them into a clinical trial should not become a barrier to getting the study started,” said Paul Taylor, Chief Product Officer at THREAD. “Our approach allows sponsors to select the technology that is best suited for their protocol and connect it to THREAD without rebuilding the study around the device. This gives teams greater flexibility to introduce DHTs faster while maintaining visibility, governance, and control over how the data is used.”
By simplifying how DHTs are connected to clinical trial workflows, THREAD gives sponsors greater freedom to adopt new technologies without introducing unnecessary integration delays or operational complexity.
To learn more about THREAD’s Digital Health Technology capabilities and to see a quick demonstration visit, https://discover.threadresearch.com/schedule-demo.
##
About THREAD
THREAD’s® purpose is to leverage its clinical research platform to enable studies for everyone, everywhere. Through its uniquely combined research technology and scientific consulting services, THREAD helps life science organizations to design, operate, and scale next-generation research studies and electronic clinical outcome assessments (eCOA) programs for participants, sites, and study teams. Through its comprehensive platform and scientific expertise, THREAD empowers studies to be accessible, efficient, and human-centered.
THREAD has been recognized as a leader by Everest Group in its Decentralized Clinical Trial Product PEAK Matrix® Assessments from 2021 through 2023, is positioned in the Leaders Category of the 2022 IDC MarketScape for R&D Decentralized Clinical Trial Technology Solutions Vendor Assessment, and is named a Major Contender in Everest Group’s Life Sciences eCOA Products PEAK Matrix® Assessment 2025.
Media Contact
Les Yates
THREAD
media@THREADresearch.com
THREAD® provides a fully configurable clinical research platform to enable studies for everyone, everywhere. Through its industry-leading technology and scientific expertise, we empower studies to be more accessible, efficient, and patient-centered.